Top 5 Stock Picks of Eli Casdin’s Casdin Capital

Page 1 of 5

In this article, we discuss the top 5 stock picks of Eli Casdin’s Casdin Capital. If you want to read our detailed analysis of Casdin’s investment philosophy and performance, go directly to Top 10 Stock Picks of Eli Casdin’s Casdin Capital.

5. Relay Therapeutics, Inc. (NASDAQ:RLAY)

Casdin Capital’s Stake Value: $115,448,000
Percentage of Casdin Capital’s Portfolio: 5.17%
Number of Hedge Fund Holders: 18

Relay Therapeutics, Inc. (NASDAQ:RLAY) is a clinical-stage, precision medicine firm that is revolutionizing the process of discovering new drugs with a primary emphasis on accelerating the development of small molecule therapies for cancer. Akash Tewari, a Jefferies analyst, initiated coverage of Relay Therapeutics, Inc. (NASDAQ:RLAY) on June 6 and assigned it an ‘Underperform’ rating and a $13 price objective.

The hedge fund managed by Eli Casdin owned more than 3.86 million shares in Relay Therapeutics, Inc. (NASDAQ:RLAY), worth over $115.45 million, representing close to 5.17% of their portfolio. According to Insider Monkey’s Q1 data, 18 hedge funds were bullish on Relay Therapeutics, Inc. (NASDAQ:RLAY), compared to 19 funds in the earlier quarter.

Out of the hedge funds being tracked by Insider Monkey, San Francisco-based investment firm Biotechnology Value Fund / BVF Inc is the leading shareholder of Relay Therapeutics, Inc. (NASDAQ:RLAY), with 4.53 million shares worth more than $135.60 million.

Page 1 of 5